Russell D. Cohen, MD, and Thomas A. Ullman, MD, summarize clinical data on JAK inhibitors in inflammatory bowel disease (IBD). In addition to discussing the rationale for targeting JAK-STAT signaling pathways, faculty discuss the clinical implications of new research for patients with IBD.
Watch videos on new data and expert analysis. Each video is 7-9 minutes. Proceed at your own pace and in any order.
Compare your knowledge with your peers.
Download a print-friendly version of the entire activity.
Incorporate slides into your library.
This activity was developed for gastroenterologists, gastroenterology fellows, and other health care professionals who have an interest in inflammatory bowel disease (Crohn's disease and ulcerative colitis).
|Available Credit:||1.00 AMA PRA Category 1 Credit™.|
|Opens:||June 28, 2017|
|Expires:||June 27, 2018|
Other Health Care Providers